Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 6,800.00
+50.00 (0.74%)
Nov 2, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 629.02 billion as of October 30, 2026. It is the 14,762nd most valuable company in the world and the 381st biggest in South Korea. Its market cap has decreased by 32.62% in one year.
Market Cap
629.02B
Enterprise Value
1.69T
Revenue
1.31T
Global Rank
Country Rank
#381 South Korea
PE Ratio
581.17
ChartMarket Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 629.02B, an increase of 88.25%. That is a compound annual growth rate of 3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 629.02B | -43.81% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kolon TissueGene | 1.18T |
| Komipharm International | 651.95B |
| Proteina | 599.21B |
| Pharmicell | 564.04B |
| Onconic Therapeutics | 549.89B |
| Hyundai Bioscience | 518.22B |
| GI Innovation | 434.19B |
| GC Corp. | 415.33B |